Gala Renee D

Gala Renee D is listed in filings as President & CEO at Jazz Pharmaceuticals PLC. This profile follows SEC Form 4 activity through Jun 5, 2026, including 17 public disclosures. Recent filings connect the profile to Jazz Pharmaceuticals PLC (JAZZ) and DexCom Inc (DXCM). The current snapshot covers public activity from Dec 9, 2024 to Jun 5, 2026. Reported amounts are shown as $1.3M to $13.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.